Skip to the content
Neurodexlogo darklogo light
  • Home
  • About Us
    • Our Team
    • Our Lab
  • Our Tech
    • ExoSort Platform
    • Our Projects
    • Publications
    • Pipeline
  • Services
    • Neurodiagnostic Platform
    • Research Services
    • ⁠Pre-Clinical Services
    • Clinical Trial Services
  • NeuroDex News
  • Contact Us
Search
Neurodex
  • Home
  • About Us
    • Our Team
    • Our Lab
  • Our Tech
    • ExoSort Platform
    • Our Projects
    • Publications
    • Pipeline
  • Services
    • Neurodiagnostic Platform
    • Research Services
    • ⁠Pre-Clinical Services
    • Clinical Trial Services
  • NeuroDex News
  • Contact Us
Home2023(Page 2)
Roche Launches Legal Battle Against Biogen
Biotech Blog

Roche Launches Legal Battle Against Biogen’s Imitative Biosimilar of Blockbuster Arthritis Drug

ervin@a2z.rs
July 15, 2023
Revolutionizing Antibody Design: Harnessing the Power of Generative AI
Biotech Blog

Revolutionizing Antibody Design: Harnessing the Power of Generative AI

ervin@a2z.rs
July 14, 2023
Lexington's Cyteir Therapeutics to Close Two Years After IPO
Biotech Blog

Lexington’s Cyteir Therapeutics to Close Two Years After IPO

ervin@a2z.rs
July 2, 2023
Roche receives FDA clearance for additional Alzheimer’s
Biotech Blog

Roche receives FDA clearance for additional Alzheimer’s disease Cerebrospinal Fluid (CSF) assays, supporting timely diagnosis and treatment decision-making

ervin@a2z.rs
June 29, 2023
Biogen and Eisai's Alzheimer's Drug, Leqembi
Biotech Blog

FDA Advisory Committee Supports Biogen and Eisai’s Alzheimer’s Drug, Leqembi

ervin@a2z.rs
June 12, 2023
Parkinson's disease
NeuroDex News

Michael J. Fox Foundation Funds Research on a Potential Parkinson’s Biomarker

Ariella Weihs
April 24, 2023
NeuroDex, Inc., Announces Award from Alzheimer’s Drug Discovery Foundation’s Diagnostics Accelerator
NeuroDex News

NeuroDex, Inc., Announces Award from Alzheimer’s Drug Discovery Foundation’s Diagnostics Accelerator

Ariella Weihs
March 28, 2023
Neurodex Presents Breakthrough Research on Exosomes for Neurodegenerative Disease Diagnosis at 'Extracellular Vesicles: Friends and Foes II' Congress
NeuroDex News

NeuroDex Presents Breakthrough Research on Exosomes for Neurodegenerative Disease Diagnosis at ‘Extracellular Vesicles: Friends and Foes II’ Congress

Ariella Weihs
March 24, 2023
NeuroDex News

NeuroDex, Inc., Announces Award from The Michael J. Fox Foundation

Ariella Weihs
January 30, 2023

Posts pagination

1 2
ervin@a2z.rs

principal scientist

The Role of Biomarkers in ALS Diagnosis & Monitoring

ervin@a2z.rs
September 10, 2025

Exploring Today’s ALS Treatment Options & Emerging Research

ervin@a2z.rs
September 3, 2025
Categories
Biotech Blog Explanation Material NeuroDex News
Follow us
w
We believe in open projects
View more

Contact Us

Company

NeuroDex Inc

  • 22 Strathmore Road
  • Natick, MA US 01760
  • in**@******ex.co
Informations
  • Terms & Conditions
  • Privacy Policy
  • FAQ Page
Resources
  • Explanation Material
  • NeuroDex News
  • Blog

© 2025 A2Z Solutions, All Rights Reserved

Back to top Drag
w
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}